Defunct Company
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
24
NCT06007092
Therapeutic Vaccine in Patients With Human Papillomavirus HPV-positive Oropharyngeal Cancer
Phase: Phase 1/2
Role: Collaborator
Start: Jul 31, 2023
Completion: Aug 31, 2026